Hum. Reprod. Advance Access originally published online on April 21, 2005
Human Reproduction 2005 20(6):1741-1745; doi:10.1093/humrep/deh820
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The relationship between mammographic density and duration of hormone therapy: effects of estrogen and estrogenprogestin
1 Department of Obstetrics and Gynecology and 2 Department of Radiology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan, ROC
3 To whom correspondence should be addressed. Email: fangping{at}cgmh.org.tw
BACKGROUND: The purpose of this study was to examine the effects of duration of hormone therapy (HT) and treatment regimens on mammographic density. METHODS: A retrospective study was carried out of of 467 post-menopausal women who received estrogen or estrogenprogestin and had regular mammographic density determination by the Breast Imaging Reporting and Data System between 1994 and 2001. RESULTS: The fraction of women using HT who had an increase in mammographic density became more important over time. Further analysis of the effects of regimens after 4 years of HT shows that the increase in mean density was much greater in women receiving combined HT than in those receiving estrogen alone. The incidence of increased mammographic density showed significantly progressive increases over the duration of combined HT from 7.5 to 22.4%. CONCLUSIONS: Although most women using HT maintained breast density at pre-treatment levels, there is a note of caution for women using long-term HT, especially those using combined estrogenprogestin.
Key words: estrogen/estrogenprogestin/hormone therapy/mammographic density/post-menopause
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. J. Kloosterboer, L. Lofgren, E. von Schoulz, B. von Schoultz, and H. A. M. Verheul Estrogen and Tibolone Metabolite Levels in Blood and Breast Tissue of Postmenopausal Women Recently Diagnosed With Early-Stage Breast Cancer and Treated With Tibolone or Placebo for 14 Days Reproductive Sciences, February 1, 2007; 14(2): 151 - 159. [Abstract] [PDF] |
||||
![]() |
A. M. Chiarelli, V. A. Kirsh, N. S. Klar, R. Shumak, R. Jong, E. Fishell, M. J. Yaffe, and N. F. Boyd Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1856 - 1862. [Abstract] [Full Text] [PDF] |
||||

